Wei Wang, Ph.D., research associate professor, has joined a $3.2 million effort to develop a promising new treatment for triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of the disease. The team is developing a new kind of drug designed to attack MDM2, a cancer-driving protein often found at high levels in TNBC and has been linked to faster tumor growth and worse outcomes for patients.

Former University of Houston College of Pharmacy Professor Frank C. Bove, a beloved and respected faculty member for 26 years until retiring in 2002, passed Jan. 24 at the age of 87.

The American Academy of Microbiology, a leadership group within the American Society for Microbiology (ASM), has elected UHCOP Professor Vincent H. Tam, Pharm.D., FIDSA, FIDP, BCIDP, to the Fellowship Class of 2026.